US 7423049
Inhibitors of p38
granted A61PA61P1/00A61P1/02
Quick answer
US patent 7423049 (Inhibitors of p38) held by Vertex Pharmaceuticals Incorporated expires Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Sep 09 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 04 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P1/00, A61P1/02, A61P1/04, A61P1/16